Shares of Bristol Myers Squibb Co. BMY rallied 1.86% to $50.94 Tuesday, on what proved to be an all-around favorable trading ...

On Monday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $50.01 which represents a slight increase of $0.60 or 1.21% from the prior close of $49.41. The stock opened at ...

The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...

Metastatic solid tumors may be curable now. Among the most profound results presented over the weekend at the European ...

Bristol Myers Squibb Co. has described proteolysis targeting chimera (PROTAC) compounds comprising a E3 ubiquitin ligase-binding moiety coupled to a proto-oncogene tyrosine-protein kinase receptor Ret ...

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company.

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is ...

Cabiralizumab is under clinical development by Bristol-Myers Squibb and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase I drugs for Glioblastoma Multiforme (GBM) ...

Clinicians are at the sharp end of the mismatch between resources and demand. As a researcher Lillian Siu, an oncologist at Toronto’s Princess Margaret Cancer Centre, is striving to break new ground ...

The player will be hoping to build on those successes at Bristol City. After joining Bristol City, Bance said “I am excited to be here and develop as a player and a person and can’t wait to ...

The beat goes on for the Milwaukee Brewers. Shrugging off their shaky play coming in, they used a tremendous start from Tobias Myers and three home runs from their offense to down the Colorado ...